Improving HPV vaccination in rural primary care settings
Implementation of Evidence-Based Strategies to Optimize HPV Vaccination in Rural Primary Care Settings
NA · Roswell Park Cancer Institute · NCT06256718
This study is testing a new approach to help doctors in rural areas give more HPV vaccinations to teenagers by training them and using community support.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 560 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Roswell Park Cancer Institute (other) |
| Locations | 1 site (Buffalo, New York) |
| Trial ID | NCT06256718 on ClinicalTrials.gov |
What this trial studies
This study evaluates the implementation of evidence-based strategies to enhance HPV vaccination rates in rural primary care settings. It focuses on addressing disparities in vaccination rates by leveraging community networks and establishing a Cancer Health Equity Community Advisory Board. The intervention, known as PC TEACH, involves training primary care providers over 12 months to implement systematic changes aimed at increasing vaccination delivery. The effectiveness of this intervention will be assessed through process and outcome evaluations, including adolescent vaccination rates.
Who should consider this trial
Good fit: Ideal candidates for this study include primary care practices in rural New York with a sufficient adolescent patient population and a commitment to improving vaccination rates.
Not a fit: Patients who do not reside in the targeted rural counties or those who are not part of the adolescent age group may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly increase HPV vaccination rates in rural communities, leading to improved cancer prevention.
How similar studies have performed: Other studies have shown success in implementing community-based interventions to improve vaccination rates, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * PRACTICES: Are located in the 20-county target region * PRACTICES: Have an adolescent patient population \>= 150 (aged 9-18) * PRACTICES: Administer adolescent vaccines (e.g., HPV, Tdap, MCV4) * PRACTICES: Are willing to share aggregate practice and patient-level data (e.g., electronic health record \[EHR\], surveys) * PARTICIPANTS: Medical providers and medical staff \>= 18 years of age * PARTICIPANTS: Primary care providers and medical office staff who deliver adolescent care at community-based primary care practice sites across 20 rural counties in central and western New York * PARTICIPANTS: Age \>= 18 years of age (no upper limit) * PARTICIPANTS: English speaking * PARENT/GUARDIAN SURVEY: Adult accompanying a child or children aged 9 to 17 * PARENT/GUARDIAN SURVEY: English speaking * PARENT/GUARDIAN SURVEY: Presenting to the participating clinic for an outpatient well child visit or regular checkup * PARENT/GUARDIAN SURVEY: Willing to complete an anonymous survey while visiting the clinic Exclusion Criteria: * Unwilling or unable to follow protocol requirements * Adults unable to complete study measures in English * Individuals who are not yet adults (infants, children, teenagers) * Cognitively impaired adults/adults with impaired decision-making capacity * Prisoners
Where this trial is running
Buffalo, New York
- Roswell Park Cancer Institute — Buffalo, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Elisa Rodriguez — Roswell Park Cancer Institute
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Human Papillomavirus Infection